Pacific Biosciences Of California (PACB) Inventory (2010 - 2026)

Pacific Biosciences Of California's Inventory history runs 17 years deep, the most recent figure standing at $51.0 million for Q1 2026.

• In Q1 2026, Inventory fell 5.53% year-over-year to $51.0 million; the TTM figure through Mar 2026 stood at $51.0 million (down 5.53% YoY), while the FY2025 annual figure was $49.3 million, down 16.12% from the prior year.
• Inventory was $51.0 million for Q1 2026 at Pacific Biosciences Of California, up from $49.3 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $68.6 million in Q2 2024 to a low of $29.6 million in Q1 2022.
• Historically, Inventory has averaged $55.1 million across 5 years, with a median of $54.0 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Inventory soared 109.13% in 2023, then declined 21.51% in 2025.
• A 5-year view of Inventory shows it stood at $50.4 million in 2022, then climbed by 12.49% to $56.7 million in 2023, then climbed by 3.67% to $58.8 million in 2024, then decreased by 16.12% to $49.3 million in 2025, then gained by 3.52% to $51.0 million in 2026.
• The last three Inventory figures came in at $51.0 million (Q1 2026), $49.3 million (Q4 2025), and $53.2 million (Q3 2025), per Business Quant data.